Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
Clinical trial NCT02321839 · COMPLETED
Trial details
- NCT number
- NCT02321839
- Sponsor
- Nagoya City University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2019-03-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.